Tag

Tagged: Translational research

Sponsored
joined 9 years, 8 months ago

BritPACT

British Psoriatic Arthritis Consortium

The British Psoriatic Arthritis ConsorTium has been created to bring together people with an interest in psoriatic arthritis.

its mission is to facilitate and advance research and best practice in psoriatic arthritis in the United Kingdom.

Its main goals are:

  • To bring together UK individuals with an interest in PsA
  • To create a UK infrastructure to undertake studies in PsA
  • To collaborate in studies improving knowledge and outcome in PsA
  • To develop and execute research ideas in PsA
  • To engage with ARUK clinical study group to facilitate research in PsA
  • To engage with the Translational Research Partnerships in PsA
  • To collaborate with BRIT-SPA
  • To collaborate with GRAPPA
  • To engage with relevant dermatology stakeholders
  • To develop and disseminate knowledge around PsA and comorbidities 
  • To ensure patient and public involvement at all levels

view this profile
joined 9 years, 10 months ago

Ignace Vergote

Chairman of the Leuven Cancer Institute, Head of the Department of Obstetrics and Gynaecology and Gynaecologic Oncology, Catholic University of Leuven

Professor Ignace Vergote is Chairman of the Leuven Cancer Institute and Head of the Department of Obstetrics and Gynaecology and Gynaecologic Oncology at the Catholic University of Leuven, Belgium. He initially trained in Obstetrics and Gynaecology at the University of Antwerp, Belgium, before specialising in Gynaecologic Oncology in the Department of Gynaecologic Oncology at the Norwegian Radium Hospital, where he later became staff member and in 1991 deputy chairman.

Professor Vergote is currently Chairman of the Belgian & Luxemburg Gynaecological Oncology Group (BGOG), and Chairman of the Protocol committee of European Organization for Research, and Treatment of Cancer -Gynecologic Cancer Group (EORTC-GCG), and President of the Society of Robotic European Gynaecological Surgery (SERGS). Professor Vergote was the founder and first chairman of ENGOT from 2007 until 2012. In 2013 he was Chairman of the Board of Medical Chairmen of the University Hospital Leuven. Since 2014 he is member of the Board of Directors of the University Hospital Leuven.

He has been Chairman of the EORTC-GCG from 1997 to 2003, and served as President of the European Society of Gynaecological Oncology (ESGO) for the period 2003-2005. For the period 2006-2008 he was the President of the International Gynecologic Cancer Society (IGCS). He has been Chairman of the Flemish Society of Obstetrics and Gynaecology from 2008 to 2013. He was founder and first chairman of the European Network of Gynaecological Oncological Trial groups (ENGOT) from 2007 tot 2012.

He received in 2004 the Wertheim price in Austria and the COBRA price for surgical expertise in the Netherlands. In 2008 he became Honorary Member of the Finnish Society of Gynaecology and Obstetrics. In 2012 he became Honorary Member of the American College of Surgeons. 

Professor Vergote’s main areas of clinical and translational research focus on ovarian and uterine cancer. He has authored more than 635 original full papers in peer-reviewed journals, together with 50 book chapters, and edited several books on Gynaecological Oncology. He is Editor of the European Journal of Cancer , and past-Associate Editor of Gynecologic Oncology and the International Journal of Gynaecological Cancer.


view this profile
joined 9 years, 11 months ago

Jalid Sehouli

Professor and Director, Department of Gynecology Campus Virchow Klinik and Campus Benjamin Franklin, Charité Medical University Berlin; Vice-President, EUTROC network

Professor Sehouli is a gynaecological oncologist, working at the Charité, University of Medicine in Berlin, Germany.


Professor Jalid Sehouli is currently the director of the department of gynecology in the famous Charité/ Campus Virchow-Klinikum and Campus Benjamin Franklin. He is also the head of the European Competence Center for Ovarian Cancer and is leading the gynaecological oncology at all three Campi at Charité Medical University in Berlin.


Professor Sehouli founded the German Foundation for ovarian cancer patients, being involved in many initiatives for patients.

Together with Professor Lichtenegger he founded the German north eastern society for gynaecological oncology (NOGGO). In 2000 he initiated the tumor bank ovarian cancer, which became the largest biobank for fresh frozen tissue worldwide.

Since 2013 Professor Sehouli was nominated as speaker for the OVAR Kommission of the AGO, Germany.


His clinical and scientific interest focuses on the surgical therapy and systemic treatment of advanced gynaecological malignancies. He lead several preclinical trials in predicting the surgical outcome. He is principle investigator in many Phase I to Phase III clinical trials in ovarian cancer.


He has published more than 250 national and international papers in the field of gynaecologic oncology.
He is a member of the executive board of the Arbeitsgemeinschaft Gynäkologische Onkologie (AGO) and the Nord-Ostdeutsche Gesellschaft für Gynäkologische Onkologie (NOGGO), and a member of the European Society of Gynaecological Oncology (ESGO), the Gynaecologic Cancer Intergroup (GCIG), the American Society of Clinical Oncology (ASCO) and the Multinational Association of Supportive Care in Cancer (MASCC).


view this profile
joined 9 years, 11 months ago

Charlie Gourley

Professor and Honorary Consultant in Medical Oncology

Charlie Gourley graduated with honours in Genetics from the University of Glasgow in 1991. He then went on to qualify as a medical doctor in 1994 also at the University of Glasgow.

Charlie progressed through his medical training in Edinburgh, continuously combining that with active research interests. He has successfully held research positions both at the University of Edinburgh and within the NHS.

Charlie’s career ladder took him to his current position as a Professor and Honorary Consultant in Medical Oncology, specialising in gynaecological cancers. He leads a clinical research team at the Edinburgh Cancer Centre, and a translational research group at the University of Edinburgh Cancer Research UK Centre.

He is a member of the National Cancer Research Network gynaecological cancers clinical studies group, the National Cancer Research Network ovarian subgroup and the Scottish Gynaecological Cancers Trials Group. He is also an active member of several other committees.


view this profile
joined 9 years, 11 months ago

Elena Ioana Braicu

Senior gynaecologist

Elena Ioana Braicu is a senior gynecologist at the Department for Gynecology Campus Vrchow, Charité Medical University Berlin. She is leading the translational research within this department, and coordinating the Tumor Bank for Ovarian Cancer network (www.toc-network.de).

She qualified in medicine in 2003 from “Iuliu Hatieganu” Medical University in Cluj-Napoca, Romania. She was research fellow at Max Delbrück Research center Berlin in 2003 and 2004, than at the Charité from 2005 and 2006 and at the University of Basel in 2008. Since 2009 she is working at the European Competence Center for Ovarian Cancer at the Charité Medical University.


She is representing the translational group of NOGGO, north eastern German society for gynecological oncology within ENGOT. She is a founding EUTROC member and is leading the working group for biobanking. She is also consultant for pediatric gynecology at the Charité Medical University.


Dr. Braicu participated in several European projects, like OVCAD (www.ovcad.eu) and OCTIPS (www.octips.eu). She is work package leader for biobanking and data repository in the Fp7 European Phase I/II clinical study, Gannet53 (www.gannet53.eu).


She is member in several national and international study groups (e.g. AGO, NOGGO, TOC, ENGOT, EUTROC, GCIG). She is member of the German Foundation of Ovarian Cancer.


Furthermore she is participating in several Phase I to Phase III clinical study as sub-investigator. She is the vice-coordinator of the clinical trial study center at the Charité Medical University.

Since 2013, she is a fellow of the clinical scientist program of the Charité Universitätsmedizin Berlin and the Berlin Institute of Health.


Her main interests are prevention and diagnostic of pelvic tumors in general and high risk population. She is focusing also in the discovery of predictive biomarkers for clinical outcome in ovarian cancer patients.

 


view this profile
joined 9 years, 11 months ago

EUTROC

European Translational Research network in Ovarian Cancer

EUTROC (European Translational Research network in Ovarian Cancer) is a European cancer network addressing the fragmentation currently hindering translational research for cutting edge therapies in ovarian cancer.

It will strengthen European excellence in the diagnosis and treatment of OC.

The need to bring promising drug candidates and treatments into clinical settings is currently delayed by the lack of standardised protocols for preclinical animal studies, lack of suitable ovarian cancer models, lack of validated predictive biomarker diagnostics, and integrated appropriate management of translational research partners (including pharma and biotech companies).

Developing effective diagnostic and treatment strategies require structured joint efforts of experts on tumor immunology, epigenetics, pathology, bioinformatics, drug development and delivery, trial development, clinical oncology and gynecological oncology.

Leading European researchers and clinicians together with the pharmaceutical industry and biotech companies will focus on preclinical and clinical studies in ovarian cancer. Therefore new targets will be identified, validated and translated to new drugs and brought to clinical practice. Standardisation and harmonisation of laboratory practices and good clinical practice procedures will BE performed within the consortium.

The consortium combines expertise in clinical as well as preclinical research. Involved researchers are coordinating a number of investigator-initiated Phase I, II trials.The Network will build a platform for research and strong educational programs for the next generation of experts aimed at developing individualised patients benefit.


view this profile
joined 10 years, 9 months ago

John Green

Senior Lecturer in Medical Oncology at University of Liverpool

John Green is a leading internationally recognised oncologist specializing in gynaecologic and ovarian cancers.


view this profile